Karlin Daniel
Definium Therapeutics, Inc. · Chief Medical Officer
Karlin Daniel is listed in filings as Chief Medical Officer at Definium Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including sale activity. Recent filings connect the profile to Definium Therapeutics, Inc. (DFTX). The current snapshot covers public activity from Mar 13, 2025 to Jun 22, 2026. Reported amounts are shown as $46.1K to $75.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $148k8k shares | SellMar 25, 2026 | $18.47 | $45.98 |